Skip to content
Agentic OS
Menu

Intelligence / Healthtech / PMA Approvals / Abbott Medical

Approvalsdevice change approved (PMA)5 Nov 2026

Abbott Medical

5 Nov 2026: Device change approved (PMA) · UltiSynq™ Defibrillation lead; SurGrip™ Suture Sleeve Accessory. Recorded in the openFDA device PMA data.

View the source record

Decided
5 Nov 2026
Device
UltiSynq™ Defibrillation lead; SurGrip™ Suture Sleeve Accessory
Specialty
Cardiovascular
Type
Supplement (Normal 180 Day Track)
Reason
Change Design/Components/Specifications/Material
Reference
P950022 S153
Location
Sylmar, CA
What this signal means

A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.

  1. Cardiovascular leads with 53 of 120, then Pathology (15).
  2. 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Abbott Medical

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Abbott Medical in our registers.

More in Cardiovascular

PMA Approvals

See all

Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.